Synthesis of Imidazothiazole–Chalcone Derivatives as Anticancer and Apoptosis Inducing Agents

A. Kamal,D. Dastagiri,M. J. Ramaiah,J. Reddy,E. V. Bharathi,Srinivas Chatla,S. Pushpavalli,D. Pal,M. Pal‐Bhadra
DOI: https://doi.org/10.1002/cmdc.201000346
IF: 3.54
2010-11-08
ChemMedChem
Abstract:A new class of imidazo[2,1‐b]thiazole chalcone derivatives were synthesized and evaluated for their anticancer activity. These chalcone derivatives show promising activity, with log GI50 values ranging from −7.51 to −4.00. The detailed biological aspects of these derivatives toward the MCF‐7 cell line were studied. Interestingly, these chalcone derivatives induced G0/G1‐phase cell‐cycle arrest, down‐regulation of G1‐phase cell‐cycle regulatory proteins such as cyclin D1 and cyclin E1, and up‐regulation of CDK4. Moreover, these compounds elicit the characteristic features of apoptosis such as enhancement in the levels of p53, p21, and p27, suppression of NF‐κB, and up‐regulation of caspase‐9. One of these chalcone derivatives, 3 d, is potentially well suited for detailed biological studies, either alone or in combination with existing therapies.
What problem does this paper attempt to address?